• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact Us
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Spring Funding Opportunities

          2021 Research Fellowships
          due April 1
          2021 Childhood Eczema Challenge Grant
          due May 4

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

North American Study of Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Setting Diagnostic Criteria, Systematic Review and Retrospective Cohort Analysis Comparing Outcomes of Common Treatments

November 10, 2019 By Mike Siegel

Principal Investigator:

Michele Ramien, MD
University of Calgary

Overview:

A critical gap exists in our knowledge of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in pediatrics. Little is known about how to accurately define the spectrum of disease or direct optimal treatment. Much of the literature we rely on to manage pediatric SJS and TEN (SJS/TEN) is extrapolated from adult studies, the applicability of which has been questioned in recent reviews. Discussion at the 2015 and 2016 PeDRA meetings with opinion leaders supports our proposal that diagnostic criteria are a critical first step to inform more detailed examination of pediatric SJS/TEN and advance clinical care.

We have three objectives:
1. Create consensus diagnostic criteria for the pediatric SJS/TEN spectrum using a combination of nominal group technique and the Delphi method;
2. Perform a systematic review of treatment responses in SJS/TEN;
3. Apply diagnostic criteria for a multicentre retrospective cohort analysis to determine optimal management and encourage standardized treatment.

Status:

This study was funded as a 2016 SPD-PeDRA Team Grant and is underway. The first of three anticipated publications is currently under review.

Participating Sites:

Filed Under: Active Studies, Inflammatory Skin Disease

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy